# venBio Partners L.P.

> Institutional holdings reported to the SEC as of Q4 2018 on Form 13F. CIK 1737053. Source: https://holderbook.com/funds/1737053-venbio-partners-l-p/

- Reported value: $38.1M
- Positions: 3
- Weight of the ten largest: 100.0%
- Filed: 2019-02-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc | - | $23.6M | 1,790,102 | 62.0% | 1 |
| VERONA PHARMA PLC | [VRNA](https://holderbook.com/stocks/VRNA/) | $8.4M | 875,000 | 22.2% | 1 |
| MENLO THERAPEUTICS INC | [MNLO](https://holderbook.com/stocks/MNLO/) | $6.0M | 1,461,552 | 15.8% | 1 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q4 2018 | $38.1M | 3 |